Cryoport, Inc. (CYRX) |
| 8.42 -0.11 (-1.29%) 02-27 16:00 |
| Open: | 8.34 |
| High: | 8.47 |
| Low: | 8.31 |
| Volume: | 222,861 |
| Market Cap: | 422(M) |
| PE Ratio: | -6.9 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Integrated Freight & Logistics |
| Sector: | Industrials |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 10.87 |
| Resistance 1: | 9.78 |
| Pivot price: | 8.47 |
| Support 1: | 8.01 |
| Support 2: | 6.66 |
| 52w High: | 11.45 |
| 52w Low: | 4.58 |
Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.
| EPS | -1.220 |
| Book Value | 9.450 |
| PEG Ratio | 0.00 |
| Gross Profit | 2.213 |
| Profit Margin (%) | 29.23 |
| Operating Margin (%) | -22.01 |
| Return on Assets (ttm) | -4.4 |
| Return on Equity (ttm) | -11.3 |
Tue, 24 Feb 2026
CryoPort (CYRX) to Release Quarterly Earnings on Tuesday - MarketBeat
Wed, 18 Feb 2026
Readystate Asset Management LP Sells 180,605 Shares of CryoPort, Inc. $CYRX - MarketBeat
Tue, 17 Feb 2026
Cryoport to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026 - Sahm
Wed, 11 Feb 2026
Cryoport’s new lab freezer runs without continuous liquid nitrogen - Stock Titan
Wed, 11 Feb 2026
Cryoport's MVE Biological Solutions Introduces New Fusion® 800 Series - PR Newswire
Fri, 23 Jan 2026
CryoPort Inc (CYRX) Shares Down 2.89% on Jan 23 - GuruFocus
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |